Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of easing COVID-19 strategies following downgrading of the national infectious disease category on COVID-19 occurrence among hospitalized patients in Japan.
Makino M, Takesue Y, Murakami Y, Morosawa M, Doi M, Ogashiwa H, Ueda T, Nakajima K, Sugiura H, Nozaki Y. Makino M, et al. Among authors: morosawa m. J Infect Chemother. 2024 Jul 6:S1341-321X(24)00182-X. doi: 10.1016/j.jiac.2024.07.004. Online ahead of print. J Infect Chemother. 2024. PMID: 38977074 Free article.
Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period.
Murakami Y, Nozaki Y, Morosawa M, Toyama M, Ogashiwa H, Ueda T, Nakajima K, Tanaka R, Takesue Y. Murakami Y, et al. Among authors: morosawa m. J Infect Chemother. 2024 Sep;30(9):853-859. doi: 10.1016/j.jiac.2024.02.026. Epub 2024 Feb 28. J Infect Chemother. 2024. PMID: 38428674 Free article.
Clinical features of pasteurellosis without an animal bite or scratch in comparison with bite/scratch pasteurellosis.
Asaeda T, Ueda T, Nozaki Y, Murakami Y, Morosawa M, Inaba H, Ogashiwa H, Doi M, Nakajima K, Shirakawa M, Nakamura A, Ikeda N, Sugiyama Y, Wada Y, Ito T, Takesue Y. Asaeda T, et al. Among authors: morosawa m. J Infect Chemother. 2024 Aug;30(8):820-823. doi: 10.1016/j.jiac.2024.02.002. Epub 2024 Feb 17. J Infect Chemother. 2024. PMID: 38373634 Free article.
Judicious ending of isolation based on reverse transcription-polymerase chain reaction (RT-PCR) cycle threshold only for patients with coronavirus disease 2019 (COVID-19) requiring in-hospital therapy for longer than 20 days after symptom onset.
Murakami Y, Ogashiwa H, Nozaki Y, Ueda T, Nakajima K, Morosawa M, Doi M, Makino M, Takesue Y. Murakami Y, et al. Among authors: morosawa m. J Infect Chemother. 2023 Aug;29(8):778-782. doi: 10.1016/j.jiac.2023.05.007. Epub 2023 May 18. J Infect Chemother. 2023. PMID: 37209841 Free PMC article.
A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients.
Yoda S, Soejima K, Yasuda H, Naoki K, Kawada I, Watanabe H, Nakachi I, Satomi R, Nakayama S, Ikemura S, Terai H, Sato T, Morosawa M, Asano K. Yoda S, et al. Among authors: morosawa m. Cancer Chemother Pharmacol. 2011 Mar;67(3):717-22. doi: 10.1007/s00280-010-1539-y. Epub 2010 Dec 9. Cancer Chemother Pharmacol. 2011. PMID: 21152917 Clinical Trial.